SPECCRO
SPECCRO

A Specialty Research Organization Dedicated to Human-Centric Tools

A Specialty Research Organization Dedicated to Human-Centric ToolsA Specialty Research Organization Dedicated to Human-Centric ToolsA Specialty Research Organization Dedicated to Human-Centric Tools

Implement Non Animal-based In Vitro & AI Tools to Advance Molecules to Patients and Enable Drug Approvals

A Specialty Research Organization Dedicated to Human-Centric Tools

A Specialty Research Organization Dedicated to Human-Centric ToolsA Specialty Research Organization Dedicated to Human-Centric ToolsA Specialty Research Organization Dedicated to Human-Centric Tools

Implement Non Animal-based In Vitro & AI Tools to Advance Molecules to Patients and Enable Drug Approvals

Discover safer & Efficacious drugs through animal-free in vitro and AI Innovations

Unlock the power of in vitro intelligence: A specialty research organization dedicated to non animal-based in vitro methods and AI tools 

Your Specialty Research Organization: SPECCRO

Preclinical Efficacy & Safety Assessment Needs a New Approach

  • 90% of new drug candidates that enter clinical trials fail due to lack of efficacy and non monitorable toxicity. 
  • Unbearable costs of drug development. 
  • FDA's recent announcement plans to phase out animal testing requirements.  

Mission/Value

  • We will provide integrated non-animal and AI based in vitro datasets and scientific expertise to accelerate safe molecules to patients
  • Superior efficacy & safety profile,  reduced attrition, reduced animal use will materially improve the cost and speed of drug development


SPECCRO Advantage

SPECCRO will be first of its kind integrated non-animal in vitro and AI-based approach to preclinical drug safety assessment. Human-relevant and evidence based approach will be integrated using innovative AI/ML  platforms that is enhanced by expert interpretation.  New approach methodologies will be fully leveraged through strategic partnerships. These innovative translatable and predictive safety assessment services will be offered at a much faster & cheaper scale

SPECCRO TEAM

Shashi Ramaiah, Founder & CEO

Todd Bucciarelli, Advisory Board Member

Todd Bucciarelli, Advisory Board Member

Todd Bucciarelli, Advisory Board Member

Todd Bucciarelli, Advisory Board Member

Todd Bucciarelli, Advisory Board Member

Brian Berridge, Advisory Board Member

Todd Bucciarelli, Advisory Board Member

Brian Berridge, Advisory Board Member

Devang Parikh, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

Brian Berridge, Advisory Board Member

Armin Wolf, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

Blanca Rodriguez, Advisory Board Member

John Burkhardt, Advisory Board Member

Chandra Williams, In Vivo Operations & Compliance

John Burkhardt, Advisory Board Member

Sandeep Menon, Advisory Board Member

Chandra Williams, In Vivo Operations & Compliance

John Burkhardt, Advisory Board Member

Chandra Williams, In Vivo Operations & Compliance

Chandra Williams, In Vivo Operations & Compliance

Chandra Williams, In Vivo Operations & Compliance

Ajith Kamath, Advisory Board Member

Corporate Counsel John Schreiner, J.D.

Chandra Williams, In Vivo Operations & Compliance

Corporate Counsel John Schreiner, J.D.

Corporate Counsel John Schreiner, J.D.

Corporate Counsel John Schreiner, J.D.

Contact Us

Drop us a line!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better yet, see us in person soon!

We love to shape the future of innovative SPECCRO offerings for our drug developers. 

SPECCRO: Unlock the power of in vitro intelligence

USA, India

contact@speccro.com

Check back for updates!

Contact us for strategic and operational alliances.

Copyright © 2025 SPECCRO - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept